RS
Ramesh Sayaboina
About Ramesh Sayaboina
Data last updated:
Ramesh Sayaboina is a Director at Milus Pharmaceuticals Private Limited (since 2023). The company operates in Chemicals. Milus Pharmaceuticals Private Limited reported revenue of ₹1.21 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Milus Pharmaceuticals Private Limited U24239MH2022PTC383611 | Director | 20 Nov 2023 | 2022 | ₹1.21 Cr (FY 2024) | Active |
Board colleagues of Ramesh Sayaboina
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kishore Keerthipati | 10380992 | Milus Pharmaceuticals Private Limited | Director |
| Narasimha Sastry Malladi | 10381421 | Milus Pharmaceuticals Private Limited | Director |
| Shoban Babu Billa | 10381187 | Milus Pharmaceuticals Private Limited | Director |
| Syed Razak Hussaini | 10381331 | Milus Pharmaceuticals Private Limited | Director |
| Tenkampet Karunakar | 10382822 | Milus Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramesh Sayaboina
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramesh Sayaboina
Ramesh Sayaboina currently holds 1 directorship: Milus Pharmaceuticals Private Limited (Director, since 20 Nov 2023, revenue ₹1.21 Cr (FY 2024)).
Ramesh Sayaboina was first appointed on 20 Nov 2023 as Director at Milus Pharmaceuticals Private Limited.
The current boards of Ramesh Sayaboina's companies include Kishore Keerthipati (Milus Pharmaceuticals Private Limited), Narasimha Sastry Malladi (Milus Pharmaceuticals Private Limited), Shoban Babu Billa (Milus Pharmaceuticals Private Limited), Syed Razak Hussaini (Milus Pharmaceuticals Private Limited), Tenkampet Karunakar (Milus Pharmaceuticals Private Limited).